Senti Biosciences Inc (SNTI)

Finanzdaten der Senti Biosciences Inc-Aktie (SNTI)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	0.338	0.937	1.286
Operating Expenses	12.82% 16.30	18.70	44.21	20.57	21.12
Operating Income/Loss	12.82% -16.30	-18.70	-43.88	-19.64	-19.83
Nonoperating Income/Loss	41,800% 4.19	0.01	7.261	0.938	1.112
Income/Loss From Continuing Operations Before Tax	85.48% -12.11	-83.41	-36.62	-18.70	-18.72
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	85.48% -12.11	-83.41	-36.62	-18.70	-18.72
Income/Loss From Discontinued Operations, Net Of Tax	100.00% -	12.35	21.69	-	-
Net Income/Loss	82.96% -12.11	-71.06	-14.92	-18.70	-18.72
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	47,275% 45.71	0.0965	44.47	44.28	44.07
Diluted Average Shares	47,275% 45.71	0.0965	44.47	44.28	44.07
Basic Earnings Per Share	38.10% -0.26	-0.42	-0.34	-0.42	-0.42
Diluted Earnings Per Share	38.10% -0.26	-0.42	-0.34	-0.42	-0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-